Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
6 pending office actions • 2 art units • 4 examiners • 0 of 6 (0%) have an AI response strategy ready
Ablative Solutions Inc. has 6 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are distributed among 4 distinct examiners and 2 distinct art units. This indicates that the company's active filings are concentrated within a few specific technical divisions and under the review of a small group of examiners.
BOSWORTH, KAMI A is the busiest examiner for the portfolio, with 3 pending office actions. This represents 3 of the total 6 pending office actions for the company. The remaining 3 actions are split among the other 3 distinct examiners. This concentration gives BOSWORTH, KAMI A a role in the company's current prosecution outcomes.
With 6 pending office actions and 4 distinct examiners, the applicant faces some variety in examiner perspectives. However, the concentration in 2 distinct art units provides a level of technical predictability. Practitioners should focus on the specific preferences of BOSWORTH, KAMI A while also managing the requirements of the other 3 examiners across the 2 Medical Devices & Mechanical Engineering art units involved.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Double-patenting only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOSWORTH, KAMI A | 3 | 69.1% | +28.7% |
| ANTISKAY, BRIAN MICHAEL | 1 | 67.2% | +39.3% |
| HALL, DEANNA K | 1 | 75.7% | +15.7% |
| TEMPLETON, MARINA DELANEY | 1 | 62.9% | +50.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17232695 | EXPANDABLE CATHETER SYSTEM FOR FLUID INJECTION INTO AND DEEP TO THE WALL OF A BLOOD VESSEL | BOSWORTH, KAMI A | 125d overdue |
| 17662343 | RADIAL COMPATIBLE CATHETER FOR PERI-VASCULAR FLUID INJECTION | BOSWORTH, KAMI A | 46d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17232695 | EXPANDABLE CATHETER SYSTEM FOR FLUID INJECTION INTO AND DEEP TO THE WALL OF A BLOOD VESSEL | BOSWORTH, KAMI A | 125d overdue |
| 18333462 | METHODS OF ABLATING TISSUE USING A CATHETER INJECTION SYSTEM | HALL, DEANNA K | 49d overdue |
| 17662343 | RADIAL COMPATIBLE CATHETER FOR PERI-VASCULAR FLUID INJECTION | BOSWORTH, KAMI A | 46d overdue |
| 19030472 | APPARATUS FOR EFFECTIVE ABLATION AND NERVE SENSING ASSOCIATED WITH DENERVATION | ANTISKAY, BRIAN MICHAEL | — |
| 18449528 | INTRAVASCULAR FLUID CATHETER WITH MINIMAL INTERNAL FLUID VOLUME | BOSWORTH, KAMI A | — |
| 16945077 | CATHETER FOR PERI-VASCULAR FLUID INJECTION | TEMPLETON, MARINA DELANEY | — |
| Art Unit | Apps |
|---|---|
| 3783 | 4 |
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19030472 | APPARATUS FOR EFFECTIVE ABLATION AND NERVE SENSING ASSOCIATED WITH DENERVATION | ANTISKAY, BRIAN MICHAEL | — | DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18449528 | INTRAVASCULAR FLUID CATHETER WITH MINIMAL INTERNAL FLUID VOLUME | BOSWORTH, KAMI A | 3783 | §103 | Final Rejection | — | Pending | Aug 14, 2023 |
| 18333462 | METHODS OF ABLATING TISSUE USING A CATHETER INJECTION SYSTEM | HALL, DEANNA K | 3783 | §103 | Final Rejection | 49d overdue | Pending | Jun 12, 2023 |
| 17662343 | RADIAL COMPATIBLE CATHETER FOR PERI-VASCULAR FLUID INJECTION | BOSWORTH, KAMI A | 3783 | §103§112 | Final Rejection | 46d overdue | Pending | May 06, 2022 |
| 17232695 | EXPANDABLE CATHETER SYSTEM FOR FLUID INJECTION INTO AND DEEP TO THE WALL OF A BLOOD VESSEL | BOSWORTH, KAMI A | 3783 | §103§112 | Non-Final OA | 125d overdue | Pending | Apr 16, 2021 |
| 16945077 | CATHETER FOR PERI-VASCULAR FLUID INJECTION | TEMPLETON, MARINA DELANEY | 3794 | §103 | Non-Final OA | — | Pending | Jul 31, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial